JING Li, FAN Kan-hua, ZHOU Qian. Antibiotics application in intracoronary coronary stenting during perioperative period[J]. Journal of Pharmaceutical Practice and Service, 2012, 30(1): 61-63. doi: 10.3969/j.issn.1006-0111.2012.01.018
Citation:
|
JING Li, FAN Kan-hua, ZHOU Qian. Antibiotics application in intracoronary coronary stenting during perioperative period[J]. Journal of Pharmaceutical Practice and Service, 2012, 30(1): 61-63. doi: 10.3969/j.issn.1006-0111.2012.01.018
|
Antibiotics application in intracoronary coronary stenting during perioperative period
- Received Date: 2011-08-22
- Rev Recd Date:
2011-10-20
-
Abstract
Objective To Sum up the situation of using antibiotics in intracoronary coronary stenting, and normalize the usage criterion and reinforce the management of antibiotics. Methods Retrospective survey method was used. 206 cases of patients who underwent cardiac intervention surgery between Jan., 2011 to May, 2011 were randomly selected for investigating and analyzing the usage of antibiotics. Results In the 260 cases, only 7 cases received no antibacterial treatment, while other 199 cases (96.6%) received prophylactic antibacterial treatment. The cephamycins was the predominant prophylactic antibiotics with the utility rate of 60.86%; the usage rate of first-generation and second-generation cephalosporins were 16.21% and 13.04% respectively; the usage rate of quinolone was 5.53%. All cases were medicated after surgery. The duration of prophylactic therapy spanned from 1d to 12 d, and the average antibacterial usage period was 3 d. Conclution The outstanding problems in prophylactic usage of antibiotics were the improper choice for the antibiotics, the improper choice for the medicinal usage occasion and the prolonged postoperative usage of antibiotics. It was urgent to intensify physicians' consciousness about rational use of antibiotics in intracoronary coronary stenting during perioperative period.
-
References
[1]
|
马爱群,胡大一.心血管病学[M].北京:人民卫生出版社,2005:609. |
[2]
|
卫生部办公厅.关于抗菌药物临床应用管理有关问题的通知.卫办医政发 |
[3]
|
38号. |
[4]
|
中华医学会外科分会,中华外科杂志编辑委员会.围手术期预防应用抗菌药物指南[J].中华外科杂志,2006,44(23):1594. |
[5]
|
段 红,田 蕾,李 严,等.心脏介入诊疗抗生素使用调查研究[J].武警医学,2003,14(11):680. |
[6]
|
褚桂芬,杨应杰,张永凤,等.循证评价妇产科围手术期预防性应用抗生素的现状[J].中国现代医学杂志,2006,16(22):3500. |
[7]
|
许恒忠,张 鉴.抗菌药物临床合理应用指南[M].北京:化学工业出版社,2008. |
[8]
|
王选锭,应可净,刘光富,等.头孢西丁与头孢美唑随机对照治疗细菌性感染124例临床评价[J].中国临床药理学杂志,1996,12(4):193. |
[9]
|
张永信.头霉素、氧头孢烯类抗生素的临床应用[J].上海医药,2004,25(1):19. |
[10]
|
汤建平,曹 加,陆 伟,等.一代头孢菌素用量与金黄色葡萄球菌耐药的相关性[J].南京医科大学学报:自然科学版,2010,30(12):1788. |
[11]
|
黎沾良.外科临床中预防性和治疗性应用抗菌药物的区别和原则[J].中国实用外科杂志,2001,21(1):4. |
[12]
|
Harbarth S,Samore MH,Lichtenberg D,et al.Prolonged antibiotic prophylaxis after cardiovascular surgery and its effect on surgical site infections and antimicrobial resistance[J].Circulation,2000,101(25):2916. |
-
-
Proportional views
-